Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system

Journal of Neuroimmunology

Volumn 146, Issue 1-2, 2004, Pages 84-93

  Shaked, Iftach ^a   Porat, Ziv ^a   Gersner, Roman ^a   Kipnis, Jonathan ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CNS inflammation; CNS trauma; EAE susceptibility; Encephalitogenicity; Genetic background; Microglia activation; Neuroprotection; Protective autoimmunity

Indexed keywords

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CELL REGENERATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CRUSH TRAUMA; FEMALE; GUINEA PIG; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGY; INJURY; METABOLISM; MICROGLIA; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; SPECIES DIFFERENCE; T LYMPHOCYTE;

EID: 0347993168     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.049     Document Type: Article

References (39)

1. Aloisi F. Immune function of microglia. Glia. 36:2001;165-179.
2. Aloisi F., Ria F., Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today. 21:2000;141-147.
3. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21:2001;6480-6491.
4. Blaugrund E., Lavie V., Cohen I., Solomon A., Schreyer D.J., Schwartz M. Axonal regeneration is associated with glial migration: comparison between the injured optic nerves of fish and rats. J. Comp. Neurol. 330:1993;105-112.
5. Damoiseaux J.G., Dopp E.A., Calame W., Chao D., MacPherson G.G., Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology. 83:1994;140-147.
6. Dijkstra C.D., Dopp E.A., van den Berg T.K., Damoiseaux J.G. Monoclonal antibodies against rat macrophages. J. Immunol. Methods. 174:1994;21-23.
7. Downen M., Amaral T.D., Hua L.L., Zhao M.L., Lee S.C. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia. 28:1999;114-127.
8. Fisher J., Levkovitch-Verbin H., Schori H., Yoles E., Butovsky O., Kaye J.F., Ben-Nun A., Schwartz M. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J. Neurosci. 21:2001;136-142.
9. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20:2000;5283-5291.
10. Hauben E., Schwartz M. Therapeutic vaccination for spinal cord injury: helping the body to cure itself. Trends Pharmacol. Sci. 24:2003;7-12.
11. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20:2000;6421-6430.
12. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 108:2001;591-599.
13. Hauben E., Mizrahi T., Agranov E., Schwartz M. Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity? Eur. J. Neurosci. 16:2002;1731-1740.
14. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194:2001;1789-1799.
15. Kerchensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation. J. Exp. Med. 189:1999;865-870.
16. Kipnis J., Schwartz M. Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol. Med. 8:2002;319-323.
17. Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I.R., Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl. Acad. Sci. U. S. A. 97:2000;7446-7451.
18. Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 21:2001;4564-4571.
19. Kipnis J., Yoles E., Mizrahi T., Ben-Nur A., Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 130:2002;78-85.
20. Lopez-Redondo F., Nakajima K., Honda S., Kohsaka S. Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Brain Res. Mol. Brain Res. 76:2000;429-435.
21. Mizrahi T., Hauben E., Schwartz M. The tissue-specific self-pathogen is the protective self-antigen: the case of uveitis. J. Immunol. 169:2002;5971-5977.
22. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:1999;49-55.
23. Moalem G., Monsonego A., Shani Y., Cohen I.R., Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13:1999;1207-1217.
24. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 15:2000;331-345.
25. Nakajima K., Honda S., Tohyama Y., Imai Y., Kohsaka S., Kurihara T. Neurotrophin secretion from cultured microglia. J. Neurosci. Res. 65:2001;322-331.
26. Nakajima K., Tohyama Y., Kohsaka S., Kurihara T. Ability of rat microglia to uptake extracellular glutamate. Neurosci. Lett. 307:2001;171-174.
27. Piani D., Frei K., Do K.Q., Cuenod M., Fontana A. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:1991;159-162.
28. Piani D., Spranger M., Frei K., Schaffner A., Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22:1992;2429-2436.
29. Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., Stokes B.T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158:1999;351-365.
30. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377:1997;443-464.
31. Popovich P.G., Stuckman S., Gienapp I.E., Whitacre C.C. Alterations in immune cell phenotype and function after experimental spinal cord injury. J. Neurotrauma. 18:2001;957-966.
32. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4:1998;814-821.
33. Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L.A., Schwartz M. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3398-3403.
34. Schwartz M., Kipnis J. Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med. 7:2001;252-258.
35. Schwartz M., Moalem G. Beneficial immune activity after CNS injury: prospects for vaccination. J. Neuroimmunol. 113:2001;185-192.
36. Takahashi T., Nieda M., Koezuka Y., Nicol A., Porcelli S.A., Ishikawa Y., Tadokoro K., Hirai H., Juji T. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 164:2000;4458-4464.
37. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21:2001;3740-3748.
38. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21:2001;3740-3748.
39. Zhang B., Yamamura T., Kondo T., Fujiwara M., Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186:1997;1677-1687.